Xanadu Quantum Technologies - Class B opened lower at $2.57, compared with its previous close of $2.80. In the last trading session, the stock traded between $2.47 and $2.68. It showed a downward intraday trend.
An investment of $100 made 1 year ago in Xanadu Quantum Technologies - Class B is now worth
$ 22.04
Resulting in a loss of
$ 77.96 (77.96%)
Note: Past profits do not guarantee future returns.
Rating from 5 Analysts
Today's Change
$-0.27 (-9.46%)
Day High
$2.68
Day Low
$2.47
Day Open
$2.57
Prev Close
$2.80
Volume
55,31,342
1W Return
-3.76%
1M Return
-27.51%
3M Return
-75.47%
6M Return
-82.84%
1Y Return
-77.96%
Market Cap ($ Mn)
242
PE Ratio
-
PB Ratio
10.20
PEG Ratio
-
ROE
-
ROCE
-86.38%
EPS (TTM)
-
1 Week
-3.76%
1 Month
-27.51%
3 Months
-75.47%
6 Months
-82.84%
9 Months
-77.96%
Xanadu Quantum Q3FY26 Results: Loss widens, revenue misses estimates
Xanadu Quantum reported Q3FY26 loss of 11 cents per share, missing the 10-cent estimate. Revenue of $1.31 million fell short of the $2.22 million consensus estimate. Canaccord Genuity cut price target to $24; RBC Capital cut to $13. Shares dropped 8.1% following the earnings release.
TodayXanadu Quantum Q3 Results: Net loss widens to $32.2M, revenue misses estimates
Net loss widened to $32.2 million from $20.3 million a year earlier. Revenue of $1.31 million missed consensus estimate of $2.22 million. Adjusted EBITDA loss expanded to $26.3 million from $15.4 million YoY. Capital expenditures rose to $8.4 million driven by chip testing equipment. Partnership with GlobalFoundries announced to scale chip manufacturing.
TodayXanadu, HyperLight cut optical switch loss to 7mdB
Optical switch insertion loss reduced to 7mdB. Nearly threefold improvement over 2025's 20 mdB benchmark. Demonstrated on HyperLight's TFLN Chiplet platform. Achieved via high-volume wafer manufacturing with high yield.
2 days agoXanadu Quantum shares slip to new 52-week low of $2.81
Xanadu Quantum shares fell to $2.81, breaking the previous 52-week low of $3.00. DARPA provisionally approved up to $10 million for Xanadu’s Stage B quantum work. Stock is down 93.4% from its 52-week high of $42.44 recorded in April. Shares traded below both 20-day ($4.27) and 50-day ($7.54) moving averages.
24 days agoXanadu Quantum secures up to $10 million from DARPA for quantum benchmarking
Xanadu Quantum Technologies received provisional approval for up to $10 million in funding from DARPA. The one-year contract extension falls under the Quantum Benchmarking Initiative (QBI). Funding will accelerate critical components of Xanadu's R&D roadmap for photonic quantum computing. Successful Stage B evaluations maintain Xanadu's path through the DARPA QBI program.
24 days agoXanadu Quantum signs multi-year deal with GlobalFoundries for production
Xanadu Quantum Technologies Ltd signed a multi-year partnership with GlobalFoundries. Deal focuses on industrializing SNSPDs and ultra-low loss SiN photonics. Production will occur on GlobalFoundries' 300 mm line in Malta, New York. Partnership aims to reduce chip overheads and increase system speed. Output serves as manufacturing foundation for future fault-tolerant demonstrators.
1mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $521.13 | -2.26% | $38,69,975.87M | 28.61 | |
| $172.40 | +2.12% | $3,97,675.94M | 160.64 | |
| $128.38 | +8.82% | $3,88,187.23M | 25.87 | |
| $234.10 | +0.15% | $2,87,592.79M | 28.43 | |
| $334.47 | +2.49% | $2,73,854.67M | 323.12 | |
| $248.22 | +1.51% | $2,34,597.93M | 20.94 | |
| $229.06 | +1.46% | $2,34,542.55M | 3,970.91 | |
| $149.26 | +1.81% | $1,80,374.29M | 103.31 | |
| $218.01 | +2.12% | $1,79,422.23M | 23.42 | |
| $253.66 | -1.88% | $1,49,846.35M | 15.14 | |
| $70.68 | +0.90% | $1,44,321.35M | 17.29 | |
| $306.36 | +0.30% | $1,20,938.37M | 26.28 |
An investment of $100 made 1 year ago in Xanadu Quantum Technologies - Class B is now worth
$ 22.04
Resulting in a loss of
$ 77.96 (77.96%)
Note: Past profits do not guarantee future returns.
